U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Severe limb shortening

MedGen UID:
331977
Concept ID:
C1835446
Finding
HPO: HP:0200083

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVSevere limb shortening

Conditions with this feature

Achondrogenesis, type IA
MedGen UID:
78546
Concept ID:
C0265273
Congenital Abnormality
The term achondrogenesis has been used to characterize the most severe forms of chondrodysplasia in humans, invariably lethal before or shortly after birth. Achondrogenesis type I is a severe chondrodystrophy characterized radiographically by deficient ossification in the lumbar vertebrae and absent ossification in the sacral, pubic and ischial bones and clinically by stillbirth or early death (Maroteaux and Lamy, 1968; Langer et al., 1969). In addition to severe micromelia, there is a disproportionately large cranium due to marked edema of soft tissues. Classification of Achondrogenesis Achondrogenesis was traditionally divided into 2 types: type I (Parenti-Fraccaro) and type II (Langer-Saldino). Borochowitz et al. (1988) suggested that achondrogenesis type I of Parenti-Fraccaro should be classified into 2 distinct disorders: type IA, corresponding to the cases originally published by Houston et al. (1972) and Harris et al. (1972), and type IB (600972), corresponding to the case originally published by Fraccaro (1952). Analysis of the case reported by Parenti (1936) by Borochowitz et al. (1988) suggested the diagnosis of achondrogenesis type II, i.e., the Langer-Saldino type (200610). Type IA would be classified as lethal achondrogenesis, Houston-Harris type; type IB, lethal achondrogenesis, Fraccaro type; and type II, lethal achondrogenesis-hypochondrogenesis, Langer-Saldino type. Superti-Furga (1996) suggested that hypochondrogenesis should be considered separately from achondrogenesis type II because the phenotype can be much milder. Genetic Heterogeneity of Achondrogenesis Achondrogenesis type IB (ACG1B; 600972) is caused by mutation in the DTDST gene (606718), and achondrogenesis type II (ACG2; 200610) is caused by mutation in the COL2A1 gene (120140).
Platyspondylic dysplasia, Torrance type
MedGen UID:
331974
Concept ID:
C1835437
Disease or Syndrome
The Torrance type of platyspondylic lethal skeletal dysplasia (PLSDT) is an autosomal dominant disorder characterized by varying platyspondyly, short ribs with anterior cupping, hypoplasia of the lower ilia with broad ischial and pubic bones, and shortening of the tubular bones with splayed and cupped metaphyses. Histology of the growth plate typically shows focal hypercellularity with slightly enlarged chondrocytes in the resting cartilage and relatively well-preserved columnar formation and ossification at the chondroosseous junction. Though generally lethal in the perinatal period, longer survival has been reported (summary by Zankl et al., 2005).

Professional guidelines

PubMed

Nossov SB, Hollin IL, Phillips J, Franklin CC
J Am Acad Orthop Surg 2022 Jul 1;30(13):e899-e910. Epub 2022 Apr 28 doi: 10.5435/JAAOS-D-21-01186. PMID: 35486897
Al Kaissi A, Ghachem MB, Nabil NM, Kenis V, Melchenko E, Morenko E, Grill F, Ganger R, Kircher SG
Orthop Surg 2018 Aug;10(3):241-246. Epub 2018 Jul 19 doi: 10.1111/os.12382. PMID: 30027601Free PMC Article
Kuwabara S
Drugs 2004;64(6):597-610. doi: 10.2165/00003495-200464060-00003. PMID: 15018590

Recent clinical studies

Etiology

Ladhani NN, Chitayat D, Nezarati MM, Laureane MC, Keating S, Silver RJ, Unger S, Velsher L, Sirkin W, Toi A, Glanc P
Prenat Diagn 2013 Nov;33(11):1039-43. Epub 2013 Aug 4 doi: 10.1002/pd.4193. PMID: 23836246
Grzegorzewski A, Synder M, Kozłowski P, Szymczak W, Bowen RJ
J Pediatr Orthop 2005 Mar-Apr;25(2):206-9. doi: 10.1097/01.bpo.0000148497.05181.51. PMID: 15718903

Diagnosis

Qian Y, Hu G, Chen M, Liu B, Yan K, Zhou C, Yu Y, Dong M
Am J Med Genet A 2021 Aug;185(8):2482-2487. Epub 2021 May 20 doi: 10.1002/ajmg.a.62260. PMID: 34014608
Ladhani NN, Chitayat D, Nezarati MM, Laureane MC, Keating S, Silver RJ, Unger S, Velsher L, Sirkin W, Toi A, Glanc P
Prenat Diagn 2013 Nov;33(11):1039-43. Epub 2013 Aug 4 doi: 10.1002/pd.4193. PMID: 23836246
Newbury-Ecob R
J Med Genet 1998 Jan;35(1):49-53. doi: 10.1136/jmg.35.1.49. PMID: 9475095Free PMC Article

Prognosis

Salinas-Torres VM
Genet Couns 2015;26(1):61-5. PMID: 26043509
Wyckoff MH, El-Turk C, Laptook A, Timmons C, Gannon FH, Zhang X, Mumm S, Whyte MP
J Clin Endocrinol Metab 2005 Feb;90(2):1233-40. Epub 2004 Nov 23 doi: 10.1210/jc.2004-0251. PMID: 15562030

Clinical prediction guides

Salinas-Torres VM
Genet Couns 2015;26(1):61-5. PMID: 26043509
Grzegorzewski A, Synder M, Kozłowski P, Szymczak W, Bowen RJ
J Pediatr Orthop 2005 Mar-Apr;25(2):206-9. doi: 10.1097/01.bpo.0000148497.05181.51. PMID: 15718903

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    • Severe limb shortening
      Severe limb shortening
      MedGen
    • Protein Deglycase DJ-1
      Protein Deglycase DJ-1
      A protein deglycase that repairs methylglyoxal- and glyoxal-glycated amino acids and proteins, releasing repaired proteins and lactate or glycolate. It deglycates CYSTEINE, AR...<br/>Year introduced: 2017
      MeSH

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...